Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-12
2011-07-12
Saeed, Kamal (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S403000, C548S241000, C548S361100, C548S362500
Reexamination Certificate
active
07977364
ABSTRACT:
The present invention relates to compounds of formula (I):in which R1, R2, R3, X, Y and A are as defined in the specification.The compounds are modulators of the estrogen receptors.
REFERENCES:
patent: 4166452 (1979-09-01), Generales, Jr.
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen et al.
patent: 6008237 (1999-12-01), Sahoo et al.
patent: 6090836 (2000-07-01), Adams et al.
patent: 2002/0086891 (2002-07-01), Aebi et al.
patent: 2002/0103229 (2002-08-01), Bhagwat et al.
patent: 2003/0171412 (2003-09-01), Malamas et al.
patent: 2003/0207927 (2003-11-01), Malamas et al.
patent: 2003/0232828 (2003-12-01), Bernotas et al.
patent: 2004/0110956 (2004-06-01), Lesuisse et al.
patent: 2004/0132794 (2004-07-01), Lesuisse et al.
patent: 2004/0180896 (2004-09-01), Munson et al.
patent: 2006/0074122 (2006-04-01), Lesuisse et al.
patent: 2007/0093479 (2007-04-01), Lesuisse et al.
patent: 2007/0155735 (2007-07-01), Lesuisse et al.
patent: 2008/0261997 (2008-10-01), Lesuisse et al.
patent: 0 882 029 (1998-12-01), None
patent: 2001288175 (2001-10-01), None
patent: WO 97/28137 (1997-08-01), None
patent: WO 00/78312 (2000-12-01), None
patent: WO 01/02369 (2001-01-01), None
patent: WO 02/098860 (2002-12-01), None
patent: WO 03/101968 (2003-12-01), None
patent: WO 2004/022544 (2004-03-01), None
patent: 2004/043354 (2004-05-01), None
patent: 2004/043933 (2004-05-01), None
patent: WO 2004/062662 (2004-07-01), None
Rudolph et al., 1,2-Benzisothiazole 1,1-Dioxides. Synthesis of 3-Alkyl-(or Aryl-)1,2-benzisothiazole 1,1-Dioxides and Related Compounds, 1974, J.C.S. Perkin I, 2589-2594.
Lala et al., Role of nitric oxide in tumor progression: Lessons from experimental tumors, Cancer and Metastasis Reviews (1998), 17, 91-106.
Golub et al., Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring, Science (1999), vol. 286, 531-537.
Robert B. Layzer, Section Five—Degenerative Diseases of the Nervous System, Cecil Textbook of Medicine, 20th edition (1996), vol. 2, pp. 2050-2057.
Antonio R. Damasio, Alzheimer's Disease and Related Dementias, Cecil Textbook of Medicine, 20th edition (1996), vol. 2, pp. 1992-1996.
FDA mulls drug to slow late-stage Alzheimer's [online], [retrieved on Sep. 23, 2003]. Retrieved from the Internet, URL; http://www.cnn.com/2003/HEALTH/conditions/09/24/alzheimers.drug.ap/index.html.
Tvaermose Nielsen et al., Aminobenzoic Acid Diurectics. 7. 3-Substituted 4-Phenyl-, 4-Arylcarbonyl-, and 4-Arylmethyl-5-sulfamoylbenzoic Acids and Related Compounds, 1975, Journal of Medicinal Chemistry, vol. 18 No. 1, pp. 41-50.
X. Yang, et al. “Preparation and Acylation of Highly Functionalized Copper Derivatives of 3-Iodoindazoles Leading to Polyfunctional 3-Acylindazoles”, Synlett, No. 13, Sep. 8, 2004, pp. 2303-2306.
Malamas, M. et al. “Design and Synthesis of Aryl Diphenolic Azoles as Potent and Selective Estrogen Receptor-beta-ligands”, Journal of Medicinal Chemistry, No. 47, Aug. 9, 2004, pp. 5021-5040.
Burkman, R. “Hormone Replacement Therapy: Current Controversies”, Minerva Ginecologica, vol. 55, No. 2, 2003, pp. 107-116.
Ramesh A. Bhat et al. “A Novel Human Estrogen Receptor β: Identification and Functional Analysis of Additional N-terminal Amino Acids.” Journal of Steroid Biochemistry & Molecular Biology 67:3 (1998): 233-240.
Hemmie H.G. Berendsen et al. “Oestradiol and Mirtazapine Restore the Disturbed Tail-Temperature of Oestrogen-Deficient Rats.” European Journal of Pharmacology 482 (2003): 329-333.
Brad R. Henke et al. “Optimization of 3-(1H-Indazol-3-ylmethyl)-1, 5-benzodiazepines as Potent, Orally Active CCK-A Agonists.” J. Med. Chem. 40 (1997): 2706-2725.
Gerard Auclerc et al. “Management of Advanced Prostate Cancer.” The Oncologist 5 (2000): 36-44.
C. Ainsworth. “Indazole Analog of Tryptamine: A New Synthesis of Indazoles.” Am. Cham. Soc. 79 (1957): 5242-5245.
Tom O. Abney. “The Potential Roles of Estrogens in Regulating Leydig Cell Development and Finction: A Review.” Steroids 64 (1999): 610-617.
Arthur M. Felix et al. “Rapid Removal of Protecting Groups from Peptides by Catalytic Transfer Hydrogenation with 1,4-Cyclohexadiene.” J. Org. Chem. 43.21 (1978): 4194-4196.
Angela M. Brodie and Vincent C.O. Njar. “Aromatase Inhibitors and their Application in Breast Cancer Treatments.” Steroids 65 (2000): 171-179.
Vincent C.O. Njar and Angela M.H. Brodie. “Comprehensive Pharmacology and Clinical Efficacy of Aromatase Inhibitors.” Drugs 58:2 (1999): 233-255.
J. Botella et al. “Lack of Estrogenic Potential of Progesterone- or 19-Nor-progesterone-derived Progestins as Opposed to Testosterone or 19-Nor-testosterone Derivatives on Endometrial Ishikawa Cells.” J. Steroid Biochem. Molec. Biol. 55:1 (1995): 77-84.
S.P.M. Crouch et al. “The Use of ATP Bioluminescence as a Measure of Cell Proliferation and Cytotoxicity.” Journal of Immunological Methods 160 (1993): 81-88.
Shaun M. Cowley et al. “Estrogen Receptors α and β Form Heterodimers on DNA.” The Journal of Biological Chemistry 272 (1997): 19858-19862.
John F. Course and Kenneth S. Kroach. “Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?” Endocrine Reviews 20 (1999): 358-417.
Simon Chu and Peter J. Fuller. “Identification of a Splice Variant of the Rat Estrogen Receptor β gene.” Molecular and Cellular Endocrinology 132 (1997): 195-199.
Haruhiko Sato et al. “Studies on Uricosuric Diuretics. II. Substituted 7,8-Dihydrofuro[2,3-g]-1,2-benzisoxazole-7carboxylic Acids and 7,8-Dihydrofuro[2,3-g]benzoxazole-7-carboxylic Acids.” Chem. Pharm. Bull. 39:7 (1991): 1760-1772.
S. Carreau et al. “Topical Review: Sources of Oestrogen in the Testis and Reproductive Tract of the Male.” International Journal of Andrology 22 (1999): 211-223.
Serdar E. Bulun et al. “Endocrine Disorders Associated with Inappropriately High Aromatase Expression.” J. Steroid Biochem. Molec. Biol 61 (1997): 133-139.
G.R. Cunha et al. “Elucidation of a Role for Stromal Steroid Hormone Receptors in Mammary Gland Growth and Development Using Tissue Recombinants.” Journal of Mammary Gland Biology and Neoplasia 2:4 (1997): 393-402.
J. Botella et al. “Structure-activity and Structure-Affinity Relationships of 19-Nor-progesterone Derivatives in Rat Uterus.” J. Endocrinol. Invest. 13 (1990): 905-910.
Heather A. Harris et al. “Characterization of the Biological Roles of Estrogen Receptors, REα and ERβ, in Estrogen Target Tissues in Vivo through the Use of an ERα-Selective Ligand.” Endocrinology 143:11 (2002): 4172-4177.
Heather A. Harris et al. “Evaluation of an Estrogen Receptor-β Agonist in Animal Models of Human Disease.” Endocrinology 144:10 (2003): 4241-4249.
Hitoshi Uno et al. “Studies on 3-Substituted 1,2-Benzisoxazole Derivatives.” Cham. Pharm. Bull. 24:4 (1976): 632-643.
H.L. Haller and P.S. Schaffer. “The Action of Isobutylmagnesium Bromide on 3,4,5-Trimethoxybenzonitrile.” J Am Chem Soc 61 (1939): 2175-2177.
Stephen Green et al. “Human Oestrogen Receptor cDNA: Sequence, Expression and Homology to v-erb-A.” Nature 320 (1986): 134-139.
E.B. Dennler and A.R. Frasca. “Synthesis of Indazoles using Polyphosohoric Acid-I.” Tetrahedron 22 (1966): 3131-3141.
Elisabetta Teodori et al. “Synthesis and Binding Properties of Photoactivable Biotin-Conjugated Verapamil Derivatives for the Study of P-170 Glycoprotein.” Bioorganic & Medicinal Chemistry 7 (1999) 1873-1880.
E.J. Corey. “Communications to the Editor: Protection of Hydroxyl Groups as tert-Butyldimethylsilyl Derivatives” Journal of the American Chemical Society 94:17 (1972): 6190-6191.
David M. Fink and Joseph T. Strupczewski. “Preparation of 6-Fluoroben
Blot Christian
Bonnet Paule
Clerc Thierry
Duc Igor
Duranti Eric
Bianchi Kristin
Hamre Schumann Mueller & Larson P.C.
Laboratoire Thermamex
Saeed Kamal
LandOfFree
Indazoles, benzisoxazoles and benzisothiazoles and their use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indazoles, benzisoxazoles and benzisothiazoles and their use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indazoles, benzisoxazoles and benzisothiazoles and their use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2671587